| 释义 |
- References
- Further reading
{{Infobox_gene}}Dishevelled binding antagonist of beta catenin 2 is a protein that in humans is encoded by the DACT2 gene. [1] References 1. ^{{cite web| title = Entrez Gene: Dishevelled binding antagonist of beta catenin 2| url = https://www.ncbi.nlm.nih.gov/gene/168002| accessdate = 2017-09-10}}
Further reading {{refbegin | 2}}- {{cite journal |vauthors=Koga Y, Yao T, Hirahashi M, Kumashiro Y, Ohji Y, Yamada T, Tanaka M, Tsuneyoshi M |title=Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence |journal=Histopathology |volume=52 |issue=5 |pages=569–77 |year=2008 |pmid=18370954 |doi=10.1111/j.1365-2559.2008.02996.x |url=}}
- {{cite journal |vauthors=Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR |title=Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score |journal=Mol. Med. |volume=16 |issue=7-8 |pages=247–53 |year=2010 |pmid=20379614 |pmc=2896464 |doi=10.2119/molmed.2009.00159 |url=}}
- {{cite journal |vauthors=Hendrickson SL, Lautenberger JA, Chinn LW, Malasky M, Sezgin E, Kingsley LA, Goedert JJ, Kirk GD, Gomperts ED, Buchbinder SP, Troyer JL, O'Brien SJ |title=Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression |journal=PLoS ONE |volume=5 |issue=9 |pages=e12862 |year=2010 |pmid=20877624 |pmc=2943476 |doi=10.1371/journal.pone.0012862 |url=}}
- {{cite journal|authorlink5=James G. Herman |vauthors=Jia Y, Yang Y, Brock MV, Zhan Q, Herman JG, Guo M |title=Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer |journal=J. Pathol. |volume=230 |issue=2 |pages=194–204 |year=2013 |pmid=22806826 |pmc=4061565 |doi=10.1002/path.4073 |url=}}
- {{cite journal |vauthors=Cheng H, Lu M, Mao LJ, Wang JQ, Li W, Wen RM, Chen JC |title=Relationships among MTHFR a1298c gene polymorphisms and methylation status of Dact1 gene in transitional cell carcinomas |journal=Asian Pac. J. Cancer Prev. |volume=13 |issue=10 |pages=5069–74 |year=2012 |pmid=23244112 |doi= |url=}}
- {{cite journal |vauthors=Zhang X, Yang Y, Liu X, Herman JG, Brock MV, Licchesi JD, Yue W, Pei X, Guo M |title=Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma |journal=Epigenetics |volume=8 |issue=4 |pages=373–82 |year=2013 |pmid=23449122 |pmc=3674046 |doi=10.4161/epi.24113 |url=}}
- {{cite journal |vauthors=Gao S, Yang Z, Zheng ZY, Yao J, Zhang F, Wu LM, Xie HY, Zhou L, Zheng SS |title=Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing |journal=World J Surg Oncol |volume=11 |issue= |pages=57 |year=2013 |pmid=23496880 |pmc=3605395 |doi=10.1186/1477-7819-11-57 |url=}}
- {{cite journal |vauthors=Hou J, Liao LD, Xie YM, Zeng FM, Ji X, Chen B, Li LY, Zhu MX, Yang CX, Qing-Zhao, Chen T, Xu XE, Shen J, Guo MZ, Li EM, Xu LY |title=DACT2 is a candidate tumor suppressor and prognostic marker in esophageal squamous cell carcinoma |journal=Cancer Prev Res (Phila) |volume=6 |issue=8 |pages=791–800 |year=2013 |pmid=23803417 |doi=10.1158/1940-6207.CAPR-12-0352 |url=}}
- {{cite journal |vauthors=Wang S, Dong Y, Zhang Y, Wang X, Xu L, Yang S, Li X, Dong H, Xu L, Su L, Ng SS, Chang Z, Sung JJ, Zhang X, Yu J |title=DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer |journal=Oncogene |volume=34 |issue=20 |pages=2575–85 |year=2015 |pmid=25023701 |pmc=4761644 |doi=10.1038/onc.2014.201 |url=}}
{{refend}}{{gene-6-stub}} |